Cargando…
Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies
OBJECTIVE: Natural history of cardiac amyloidosis (CA) is poorly understood. We aimed to examine the changing mortality of different types of CA over a 30-year period. PATIENTS AND METHODS: Consecutive patients included in the “Trieste CA Registry” from January 1, 1990 through December 31, 2021 were...
Autores principales: | Porcari, Aldostefano, Allegro, Valentina, Saro, Riccardo, Varrà, Guerino Giuseppe, Pagura, Linda, Rossi, Maddalena, Lalario, Andrea, Longo, Francesca, Korcova, Renata, Dal Ferro, Matteo, Perkan, Andrea, Dore, Franca, Bussani, Rossana, De Sabbata, Giovanni Maria, Zaja, Francesco, Merlo, Marco, Sinagra, Gianfranco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677956/ https://www.ncbi.nlm.nih.gov/pubmed/36419501 http://dx.doi.org/10.3389/fcvm.2022.1026440 |
Ejemplares similares
-
Re-Definition of the Epidemiology of Cardiac Amyloidosis
por: Rossi, Maddalena, et al.
Publicado: (2022) -
Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination
por: Porcari, Aldostefano, et al.
Publicado: (2021) -
Light-chain cardiac amyloidosis: a case report of extraordinary
sustained pathological response to cyclophosphamide, bortezomib, and
dexamethasone combined therapy
por: Porcari, Aldostefano, et al.
Publicado: (2022) -
A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentation
por: Nuzzi, Vincenzo, et al.
Publicado: (2023) -
Endomyocardial biopsy in the clinical context: current indications and challenging scenarios
por: Porcari, Aldostefano, et al.
Publicado: (2022)